These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 30366190

  • 1. In silico screening of a novel scaffold for fructose-1,6-bisphosatase (FBPase) inhibitors.
    Huang Y, Chi B, Xu Y, Song R, Wei L, Rao L, Feng L, Ren Y, Wan J.
    J Mol Graph Model; 2019 Jan; 86():142-148. PubMed ID: 30366190
    [Abstract] [Full Text] [Related]

  • 2. Discovery of novel indole derivatives as allosteric inhibitors of fructose-1,6-bisphosphatase.
    Bie J, Liu S, Li Z, Mu Y, Xu B, Shen Z.
    Eur J Med Chem; 2015 Jan 27; 90():394-405. PubMed ID: 25461330
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Biological evaluation and SAR analysis of novel covalent inhibitors against fructose-1,6-bisphosphatase.
    Han X, Huang Y, Wei L, Chen H, Guo Y, Tang Z, Hu W, Xia Q, Wang Q, Yan J, Ren Y.
    Bioorg Med Chem; 2020 Sep 15; 28(18):115624. PubMed ID: 32828433
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Development of disulfide-derived fructose-1,6-bisphosphatase (FBPase) covalent inhibitors for the treatment of type 2 diabetes.
    Xu YX, Huang YY, Song RR, Ren YL, Chen X, Zhang C, Mao F, Li XK, Zhu J, Ni SS, Wan J, Li J.
    Eur J Med Chem; 2020 Oct 01; 203():112500. PubMed ID: 32711108
    [Abstract] [Full Text] [Related]

  • 9. Protein-based alignment in 3D-QSAR of FBPase inhibitors.
    Yi P, Di YT, Liu W, Hao XJ, Ming Y, Huang DS, Yang J, Yi ZZ, Li ZJ, Yang RD, Zhang JC.
    Eur J Med Chem; 2011 Mar 01; 46(3):885-92. PubMed ID: 21269737
    [Abstract] [Full Text] [Related]

  • 10. Discovery of novel allosteric site and covalent inhibitors of FBPase with potent hypoglycemic effects.
    Huang Y, Wei L, Han X, Chen H, Ren Y, Xu Y, Song R, Rao L, Su C, Peng C, Feng L, Wan J.
    Eur J Med Chem; 2019 Dec 15; 184():111749. PubMed ID: 31589992
    [Abstract] [Full Text] [Related]

  • 11. Structure-guided design of AMP mimics that inhibit fructose-1,6-bisphosphatase with high affinity and specificity.
    Erion MD, Dang Q, Reddy MR, Kasibhatla SR, Huang J, Lipscomb WN, van Poelje PD.
    J Am Chem Soc; 2007 Dec 19; 129(50):15480-90. PubMed ID: 18041833
    [Abstract] [Full Text] [Related]

  • 12. Ligand-based designing, in silico screening, and biological evaluation of new potent fructose-1,6-bisphosphatase (FBPase) inhibitors.
    Tayyem RF, Zalloum HM, Elmaghrabi MR, Yousef AM, Mubarak MS.
    Eur J Med Chem; 2012 Oct 19; 56():70-95. PubMed ID: 22960695
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and structure-activity relationship of non-phosphorus-based fructose-1,6-bisphosphatase inhibitors: 2,5-Diphenyl-1,3,4-oxadiazoles.
    Liao BR, He HB, Yang LL, Gao LX, Chang L, Tang J, Li JY, Li J, Yang F.
    Eur J Med Chem; 2014 Aug 18; 83():15-25. PubMed ID: 24946215
    [Abstract] [Full Text] [Related]

  • 14. Orally active aminopyridines as inhibitors of tetrameric fructose-1,6-bisphosphatase.
    Hebeisen P, Haap W, Kuhn B, Mohr P, Wessel HP, Zutter U, Kirchner S, Ruf A, Benz J, Joseph C, Alvarez-Sánchez R, Gubler M, Schott B, Benardeau A, Tozzo E, Kitas E.
    Bioorg Med Chem Lett; 2011 Jun 01; 21(11):3237-42. PubMed ID: 21550236
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Fructose-1,6-bisphosphatase inhibitors. 1. Purine phosphonic acids as novel AMP mimics.
    Dang Q, Brown BS, Liu Y, Rydzewski RM, Robinson ED, van Poelje PD, Reddy MR, Erion MD.
    J Med Chem; 2009 May 14; 52(9):2880-98. PubMed ID: 19348494
    [Abstract] [Full Text] [Related]

  • 17. Design, synthesis and biological evaluation of 7-nitro-1H-indole-2-carboxylic acid derivatives as allosteric inhibitors of fructose-1,6-bisphosphatase.
    Bie J, Liu S, Zhou J, Xu B, Shen Z.
    Bioorg Med Chem; 2014 Mar 15; 22(6):1850-62. PubMed ID: 24530031
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Designing inhibitors against fructose 1,6-bisphosphatase: exploring natural products for novel inhibitor scaffolds.
    Heng S, Harris KM, Kantrowitz ER.
    Eur J Med Chem; 2010 Apr 15; 45(4):1478-84. PubMed ID: 20116906
    [Abstract] [Full Text] [Related]

  • 20. New insight into the binding modes of TNP-AMP to human liver fructose-1,6-bisphosphatase.
    Han X, Huang Y, Zhang R, Xiao S, Zhu S, Qin N, Hong Z, Wei L, Feng J, Ren Y, Feng L, Wan J.
    Spectrochim Acta A Mol Biomol Spectrosc; 2016 Aug 05; 165():155-160. PubMed ID: 27137358
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.